DETERMINANTS OF USMCA COMPETITIVE FORCE FORMATION
Baltic Journal of Economic Studies, 2023 Understanding the factors that influence the formation of the competitive force within the United States-Mexico-Canada Agreement (USMCA) is crucial for delineating the features that contribute to the effective functioning and development of its economic competitive landscape.
Mykola Palinchak +3 more
openaire +3 more sources
Revisiting the public health implications of the United States-Mexico- Canada agreement. [PDF]
Global Health, 2020 This commentary re-examines a recent article by Labonté et al on the recent changes to two relevant provisions relating to patent rights in the final version of the United-States-Mexico-Canada Agreement (USMCA). Although the USMCA’s final revised version
Adekola TA.
europepmc +2 more sources
USMCA 2.0: a few improvements but far from a 'healthy' trade treaty. [PDF]
Global Health, 2020 The USMCA (NAFTA 2.0), although signed over a year ago, went through several months of renegotiation of certain of its new rules that the Democrat-controlled US Congress wanted altered or strengthened.
Labonté R, Gleeson D, McNamara CL.
europepmc +2 more sources
Hollow Threats: Transnational Food and Beverage Companies' Use of International Agreements to Fight Front-of-Pack Nutrition Labeling in Mexico and Beyond. [PDF]
Int J Health Policy Manag, 2022 In October 2019, the Mexican government reformed its General Health Law thus establishing the warning approach to front-of-pack nutrition labeling (FOPNL), and in March 2020, modified its national standard, revamping its ineffective FOPNL, one ...
Crosbie E, Carriedo A, Schmidt L.
europepmc +2 more sources
USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health. [PDF]
Global Health, 2019 Background In late 2018 the United States, Canada, and Mexico signed a new trade agreement (most commonly referred to by its US-centric acronym, the United States-Mexico-Canada Agreement, or USMCA) to replace the 1994 North American Free Trade Agreement (
Labonté R +3 more
europepmc +2 more sources
Intellectual property and access to medicines: mapping public attitudes toward pharmaceuticals during the United States-Mexico-Canada Agreement (USMCA) negotiation process. [PDF]
Global Health, 2021 Background Transparency and accountability are essential components at all stages of the trade negotiation process. This study evaluates the extent to which these principles were upheld in the United States’ public consultation process during the ...
Wong ASY, Cole CB, Kohler JC.
europepmc +2 more sources
Perspectives of US-Mexico Trade under the USMCA
Norteamérica, 2021 The USMCA will impose a restructuring of the North American supply chains to meet the new input content requirements. To evaluate the determinants of the US-Mexico trade under the new agreement, an econometric model is estimated. The estimations indicate that the distance from the US states to the Mexican border and the size of the economies of the ...
Jorge Eduardo Mendoza Cota
openaire +4 more sources
Correction to: USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health. [PDF]
Global Health, 2019 Following publication of the original article [1], the authors flagged an error concerning two missing article references, which were unfortunately not provided prior to publication of the article.
Labonté R +3 more
europepmc +2 more sources
From NAFTA to USMCA: Two’s Company, Three’s a Crowd
Latin American Journal of Trade Policy, 2019 The renegotiation of NAFTA was surrounded by a dramatic atmosphere, just as Canadian Minister of Foreign Affairs Chrystia Freeland predicted. The negotiations took place against a backdrop of unilateral trade measures, President Trump’s mercantilist approach to trade policy, and the United States’ specified preference for bilateral trade deals.
Bradly J. Condon
openaire +3 more sources
Why "American Patients First" is likely to raise drug prices outside of the United States. [PDF]
J Mark Access Health Policy, 2019 Background: The Trump administration’s ‘American Patients First’ blueprint proposes to reduce drug prices in the USA by increasing drug prices abroad, ex USA.
Dabbous M +7 more
europepmc +2 more sources